Peskind ER

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (9)

Title : The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial - Raskind_2004_Arch.Neurol_61_252
Author(s) : Raskind MA , Peskind ER , Truyen L , Kershaw P , Damaraju CV
Ref : Archives of Neurology , 61 :252 , 2004
Abstract : Raskind_2004_Arch.Neurol_61_252
ESTHER : Raskind_2004_Arch.Neurol_61_252
PubMedSearch : Raskind_2004_Arch.Neurol_61_252
PubMedID: 14967774

Title : Pharmacologic treatments of dementia - Bonner_2002_Med.Clin.North.Am_86_657
Author(s) : Bonner LT , Peskind ER
Ref : Med Clin North Am , 86 :657 , 2002
Abstract : Bonner_2002_Med.Clin.North.Am_86_657
ESTHER : Bonner_2002_Med.Clin.North.Am_86_657
PubMedSearch : Bonner_2002_Med.Clin.North.Am_86_657
PubMedID: 12171061

Title : Plasma catecholamine and cardiovascular responses to physostigmine in Alzheimer's disease and aging - Petrie_2001_Psychoneuroendocrinology_26_147
Author(s) : Petrie EC , Peskind ER , Dobie DJ , Veith RC , Raskind MA
Ref : Psychoneuroendocrinology , 26 :147 , 2001
Abstract : Petrie_2001_Psychoneuroendocrinology_26_147
ESTHER : Petrie_2001_Psychoneuroendocrinology_26_147
PubMedSearch : Petrie_2001_Psychoneuroendocrinology_26_147
PubMedID: 11087961

Title : Alzheimer's disease and related disorders - Raskind_2001_Med.Clin.North.Am_85_803
Author(s) : Raskind MA , Peskind ER
Ref : Med Clin North Am , 85 :803 , 2001
Abstract : Raskind_2001_Med.Clin.North.Am_85_803
ESTHER : Raskind_2001_Med.Clin.North.Am_85_803
PubMedSearch : Raskind_2001_Med.Clin.North.Am_85_803
PubMedID: 11349485

Title : Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group - Raskind_2000_Neurology_54_2261
Author(s) : Raskind MA , Peskind ER , Wessel T , Yuan W
Ref : Neurology , 54 :2261 , 2000
Abstract : Raskind_2000_Neurology_54_2261
ESTHER : Raskind_2000_Neurology_54_2261
PubMedSearch : Raskind_2000_Neurology_54_2261
PubMedID: 10881250

Title : Pharmacologic approaches to cognitive deficits in Alzheimer's disease - Peskind_1998_J.Clin.Psychiatry_9_22
Author(s) : Peskind ER
Ref : J Clin Psychiatry , 9 :22 , 1998
Abstract : Peskind_1998_J.Clin.Psychiatry_9_22
ESTHER : Peskind_1998_J.Clin.Psychiatry_9_22
PubMedSearch : Peskind_1998_J.Clin.Psychiatry_9_22
PubMedID: 9720483

Title : Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and gender - Peskind_1996_Biol.Psychiat_40_61
Author(s) : Peskind ER , Raskind MA , Wingerson D , Pascualy M , Thal LJ , Dobie DJ , Wilkinson CW
Ref : Biological Psychiatry , 40 :61 , 1996
Abstract : Peskind_1996_Biol.Psychiat_40_61
ESTHER : Peskind_1996_Biol.Psychiat_40_61
PubMedSearch : Peskind_1996_Biol.Psychiat_40_61
PubMedID: 8780856

Title : Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma - Peskind_1995_Biol.Psychiat_38_532
Author(s) : Peskind ER , Wingerson D , Pascualy M , Thal L , Veith RC , Dorsa DM , Bodenheimer S , Raskind MA
Ref : Biological Psychiatry , 38 :532 , 1995
Abstract : Peskind_1995_Biol.Psychiat_38_532
ESTHER : Peskind_1995_Biol.Psychiat_38_532
PubMedSearch : Peskind_1995_Biol.Psychiat_38_532
PubMedID: 8562665

Title : Lack of cholinergic regulation of vasopressin and norepinephrine responses to hypertonic saline in humans - Pascualy_1995_Psychoneuroendocrinology_20_679
Author(s) : Pascualy M , Peskind ER , Wingerson D , van Belle G , Veith RC , Dorsa DM , Raskind MA
Ref : Psychoneuroendocrinology , 20 :679 , 1995
Abstract : Pascualy_1995_Psychoneuroendocrinology_20_679
ESTHER : Pascualy_1995_Psychoneuroendocrinology_20_679
PubMedSearch : Pascualy_1995_Psychoneuroendocrinology_20_679
PubMedID: 8848515